RxDoctor Payments Data

Elizabeth Marcinek, APRN

Nurse Practitioner · Huntley, ILNPI 1467827907

Payments from drug & device makers

$1,598in general payments, 2019–2025

Across 42 payments — averaging $38.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$519
  • Johnson & Johnson$330
  • Boston Scientific$284
  • E.r. Squibb & Sons, L.L.C.$133
  • Alnylam Pharmaceuticals Inc.$116
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$104
  • plus $112 from 4 others

What the payments were for

  • Food & beverage$1,598100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,598 in reported general payments places this provider in the 85th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$81,836
Medicare patients
422
Services billed
1,333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban189$190,604
XareltoRivaroxaban57$70,496
Metoprolol Succinate255$3,179
Dabigatran EtexilateDabigatran Etexilate Mesylate11$2,653
Amiodarone Hcl92$1,433
Flecainide Acetate30$1,145
Diltiazem 24hr Er (Cd)Diltiazem Hcl49$1,035
SotalolSotalol Hcl50$566
Carvedilol34$347
ClopidogrelClopidogrel Bisulfate27$340
Metoprolol Tartrate52$319
Isosorbide Mononitrate ErIsosorbide Mononitrate20$294
Potassium Chloride21$280
Atorvastatin Calcium37$158
Amlodipine Besylate24$140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$330$70,49657 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Huntley

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →